3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fallopian Tube Neoplasms
4
Ovarian Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sarcoma, Alveolar Soft Part
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Leiomyosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Colorectal Neoplasms
1
Carcinosarcoma
1
Carcinoma, Endometrioid
1
Interventions
pembrolizumab
45
Paclitaxel
42
Carboplatin
34
Bevacizumab
18
Specimen Handling
17
Letrozole
16
lenvatinib
13
Magnetic Resonance Spectroscopy
12
dostarlimab
11
Cisplatin
11
Biopsy
11
Taxes
10
olaparib
9
Fulvestrant
9
Doxorubicin
9
abemaciclib
8
Megestrol Acetate
8
Docetaxel
8
durvalumab
7
atezolizumab
7
Nivolumab
7
Gemcitabine
7
Blood Specimen Collection
7
palbociclib
6
Oxaliplatin
6
Observation
6
Fluorouracil
6
niraparib
5
Surveys and Questionnaires
5
Progestins
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
cediranib
×
1 year
×
Clear all
No trials found.